NEW YORK, 12 october 2020 / PRNewswire / – Responding to the urgent need for additional specialists to address the growing prevalence of people with Parkinson’s disease (PD), the International Parkinson and Movement Disorder Society has organized the fifth edition of the Pan American Section (MDS -NO) Movement Disorders School for Neurology Residents “on October 10, 2020. Sponsored by the Edmond J. Safra Foundation and the Michael J. Fox Foundation for Parkinson’s Research (MJFF), the one-day virtual course had 344 registered participants – including neurology residents, medical students , nurse practitioners and other health professionals from around the world. Americas – who received educational lectures, panel discussions, live patient reviews and video case studies on Parkinson’s disease and other movement disorders. Online programming has enabled the largest and most diverse course participation since its inception.
An immediate and growing global need for Parkinson’s disease specialists
It is estimated that 6 million people worldwide live with Parkinson’s disease. As the population ages, scientists predict that number could double by 2040. With the growing population of PD comes a growing need for more movement disorders specialists (MDSs) – neurologists who follow additional training in the treatment of people with Parkinson’s disease. These experts can help manage new and evolving symptoms, coordinate comprehensive treatment plans, and connect patients to the latest research opportunities. Yet, according to a 2015 survey conducted by Harris Poll on behalf of the MJFF, only 28% of patients with Parkinson’s disease are treated by a movement disorder specialist.
“The need for specialists with a solid understanding of Parkinson’s disease has never been greater,” said Rachel Dolhun, MD, MDS-PAS School of Movement Disorders Course Organizer for Neurology Residents, Fellowship-trained MDS, and MJFF Vice President of Medical Communications. “The Foundation is focused on creating opportunities like the Movement Disorders School to provide education and stimulate professional curiosity, and ultimately inspire the next generation to pursue career paths in caring for the growing Parkinson’s population.”
Led by internationally renowned experts, the annual School of Movement Disorders offers courses in the care, drug research and development in PD and other movement disorders and encourages consideration of careers in this field. . With the leadership of nine prominent clinicians and faculty from academic institutions across United States, the 2020 course was co-led by Steven J. Frucht, MD, director of movement disorders at NYU Langone and Tanya simuni, MD, professor of neurology and head of the movement disorders division at Northwestern University Feinberg School of Medicine. This year’s program included an inaugural conference on health care disparities given by Nabila Dahodwala, MD, assistant professor of neurology at the University of Pennsylvania. As of 2016, the course has attracted 678 neurology residents and other interested health care providers from North, Central, South America and the Caribbean.
Former course participants shared their thoughts on what the event meant for their education:
- “I intend to specialize in movement disorders, a decision I made after the course that has had a huge impact on my career.”
- “I have never had such an in-depth knowledge of movement disorders!”
- “Now I have a better understanding of movement disorders, their different presentations and possible planning strategies. This will make it easier for me to diagnose my findings and make a plan for each patient. “
Additional support for the MDS-PAS Movement Disorders School is provided by sponsors in the biotechnology and pharmaceutical industry, including Abbott Laboratories, AbbVie, Acadia Pharmaceuticals, Biogen, Boston Scientific, Lundbeck, Sanofi-Genzyme, and Sunovion Pharmaceuticals, Inc. This Corporate sponsorship supports the Foundation’s commitment to creating high-quality educational resources while preserving a history of effectiveness in managing donor contributions for maximum impact on the development of Parkinson’s disease drugs.
The Foundation’s continued commitment to supporting the next generation of clinicians with Parkinson’s disease
Even when neurology residents choose a career in movement disorders, the lack of funding for additional training has always made it difficult for them to gain the experience necessary to become specialists. In response to this need, the MJFF and the Edmond J. Safra Foundation have joined forces to create the Edmond J. Safra Fellowship on Movement Disorders. Launched in 2014, this program annually selects five world-renowned medical centers to each train a movement disorders clinician-researcher over two years. (Due to a generous increase in support from the Edmond J. Safra Foundation, the 2024 and 2025 classes will each train eight new movement disorders specialists.) By 2025, the Edmond J. Safra Movement Disorders Fellowship will graduate 48 new movement disorders. specialists in communities around the world to treat patients and conduct research on the most pressing patient needs. These education and training programs demonstrate MJFF’s commitment to serving the millions of people with PD through investments that link Parkinson’s research to clinical care.
About the Michael J. Fox Foundation for Parkinson’s Research
As the world’s largest nonprofit funder of Parkinson’s disease research, the Michael J. Fox Foundation is dedicated to accelerating recovery from Parkinson’s disease and improving therapies. for people living with the disease today. The Foundation pursues its goals through a highly targeted and aggressively funded research program, coupled with an active global engagement of scientists, Parkinson’s disease patients, business leaders, clinical trial participants, donors and volunteers. In addition to financing more than $ 950 million in research to date, the foundation has fundamentally altered the trajectory of progress toward a cure. Operating at the heart of global Parkinson’s research, the Foundation forges ground-breaking collaborations with industry leaders, academic scientists and government funders; increases the flow of participants in Parkinson’s disease clinical trials with its online tool, Fox Trial Finder; promotes awareness of Parkinson’s disease through large-scale advocacy, events and awareness raising; and coordinates the grassroots involvement of thousands of Team Fox members around the world. For more information visit us on the web, Facebook, Twitter, LinkedIn and Pinterest.
SOURCE The Michael J. Fox Foundation for Parkinson’s Research